Barclays Downgrades Gilead Sciences (GILD) to Equalweight

Barclays downgraded Gilead Sciences (NASDAQ: GILD) from Overweight to Equalweight, price target lowered froM $67 to $53.

For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.

Shares of Gilead Sciences closed at $47.00 yesterday, with a 52 week range of $34.45-$56.50.

---

Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• Nomura Securities Maintains a 'Buy' on Melco Crown Entertainment (MPEL); Raising PT and Estimates
• Barclays Cuts PT and Estimates on Dell (DELL); Apple's (AAPL) Momentum Proves Disrupting
• Brean Murray Carret & Co. Downgrades NetApp (NTAP) to Hold; Visibility Challenged

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

Barclays

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter